| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Harrison DG | |
| P2860 | cites work | Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells | Q28290518 |
| p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells | Q28572118 | ||
| Up‐regulation of endothelial nitric oxide synthase expression by cyclic guanosine 3′,5′‐monophosphate | Q30464214 | ||
| Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase | Q31172360 | ||
| The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine | Q33882001 | ||
| Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance | Q34194262 | ||
| Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein | Q34206300 | ||
| Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. | Q34223377 | ||
| Kinetics of cytochrome c2+ oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide-producing biological systems | Q34313420 | ||
| Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone | Q34378188 | ||
| p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats | Q34411966 | ||
| Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension | Q34415739 | ||
| Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients | Q34440940 | ||
| Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta | Q34555162 | ||
| L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans | Q35606367 | ||
| Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells | Q35763125 | ||
| Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta | Q35818430 | ||
| Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit | Q35822869 | ||
| Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug | Q37359995 | ||
| Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. | Q37362273 | ||
| The vascular effects of L-Arginine in humans. The role of endogenous insulin | Q37363072 | ||
| Nitric oxide synthases: which, where, how, and why? | Q37374087 | ||
| Superoxide and peroxynitrite in atherosclerosis | Q37558573 | ||
| The endothelial cell nitric oxide synthase: is it really constitutively expressed? | Q40399670 | ||
| L-arginine does not restore endothelial dysfunction in atherosclerotic rabbit aorta in vitro. | Q41165271 | ||
| Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits | Q41169284 | ||
| Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases | Q41215964 | ||
| Role of the enzyme calmodulin-binding domain in membrane association and phospholipid inhibition of endothelial nitric oxide synthase | Q41334662 | ||
| Endothelial control of vasomotion and nitric oxide production: a potential target for risk factor management | Q41386323 | ||
| Generation of superoxide by purified brain nitric oxide synthase | Q41590269 | ||
| Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells | Q41665885 | ||
| Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension | Q42476818 | ||
| An NADPH oxidase superoxide-generating system in the rabbit aorta | Q42480478 | ||
| NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium | Q42495148 | ||
| Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. | Q42519401 | ||
| Regulation of L-arginine transport and nitric oxide release in superfused porcine aortic endothelial cells | Q42521287 | ||
| Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries | Q44026838 | ||
| Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta | Q44068968 | ||
| Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production | Q46641954 | ||
| Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure | Q46861533 | ||
| Properties of a superoxide anion-generating microsomal NADH oxidoreductase, a potential pulmonary artery PO2 sensor. | Q50767301 | ||
| NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonate-activatable superoxide-generating system. | Q52489900 | ||
| Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. | Q54225996 | ||
| L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. | Q54310603 | ||
| Cytokines regulate endotoxin stimulation of endothelial cell arginine transport. | Q54617709 | ||
| Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells | Q63365807 | ||
| Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine | Q68326802 | ||
| Role of cytochrome b-559 in arachidonic acid activation of resting human neutrophils | Q69840367 | ||
| Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression | Q71607436 | ||
| Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine | Q71702928 | ||
| Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress | Q71720438 | ||
| Selective induction of a cationic amino acid transporter by tumor necrosis factor-alpha in vascular endothelium | Q71747946 | ||
| Antioxidative Activity of 5,6,7,8-Tetrahydrobiopterin and its Inhibitory Effect on Paraquat-Induced Cell Toxicity in Cultured Rat Hepatocytes | Q71795059 | ||
| Antioxidant vitamin C improves endothelial dysfunction in chronic smokers | Q71884045 | ||
| Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium | Q72285314 | ||
| Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle | Q72383072 | ||
| Endothelial Gi protein in human coronary arteries | Q72862370 | ||
| Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin | Q73010911 | ||
| Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese | Q73186362 | ||
| Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease | Q73303024 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 2153-2157 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Cellular and molecular mechanisms of endothelial cell dysfunction | |
| P478 | volume | 100 |
| Q28288942 | 20-HETE and blood pressure regulation: clinical implications |
| Q21284500 | A comprehensive review on metabolic syndrome |
| Q33734920 | A genetic study of the NOS3 gene for ischemic stroke in a Chinese population. |
| Q37668094 | A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy. |
| Q43786541 | A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation |
| Q36682924 | ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase. |
| Q40039555 | Activated pericyte attenuates endothelial functions: nitric oxide-cGMP rescues activated pericyte-associated endothelial dysfunctions |
| Q33639171 | Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids. |
| Q43069827 | Adult rats are more sensitive to the vascular effects induced by hyperhomocysteinemia than young rats |
| Q37784448 | Advances in pharmacologic modulation of nitric oxide in hypertension |
| Q35954921 | Aging enhances pressure-induced arterial superoxide formation |
| Q43512710 | Altered endothelium-dependent relaxations in lambs with high pulmonary blood flow and pulmonary hypertension |
| Q46762019 | An NADPH sensor protein (HSCARG) down-regulates nitric oxide synthesis by association with argininosuccinate synthetase and is essential for epithelial cell viability |
| Q34239830 | Angiotensin II and atherosclerosis |
| Q33682573 | Anti-inflammatory properties of C-Peptide |
| Q46877758 | Antioxidant N-acetylcysteine restores systemic nitric oxide availability and corrects depressions in arterial blood pressure and heart rate in diabetic rats. |
| Q28829961 | Antioxidant and Vasodilator Activity of Ugni molinae Turcz. (Murtilla) and Its Modulatory Mechanism in Hypotensive Response |
| Q44432872 | Antioxidative properties of brown algae polyphenolics and their perspectives as chemopreventive agents against vascular risk factors |
| Q41418327 | Application of galangin, an active component of Alpinia officinarum Hance (Zingiberaceae), for use in drug-eluting stents |
| Q40974366 | Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells |
| Q44601105 | Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels |
| Q26991946 | Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis |
| Q37012975 | Assessment of Oxidative Stress Markers and Carotid Artery Intima-Media Thickness in Elderly Patients Without and with Coronary Artery Disease |
| Q43734462 | Assessment of oxidative, inflammatory, and fibrinolytic biomarkers and DNA strand breakage in hypercholesterolemia. |
| Q37364334 | Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease |
| Q37172222 | Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites |
| Q36861289 | Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease |
| Q35533251 | Asymmetric dimethylarginine and whole blood viscosity in renal failure |
| Q34201581 | Asymmetric dimethylarginine: a novel cardiovascular risk factor in end-stage renal disease |
| Q34618889 | Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease |
| Q84418707 | Beneficial effects of the active principle component of Korean cabbage kimchi via increasing nitric oxide production and suppressing inflammation in the aorta of apoE knockout mice |
| Q73599611 | Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events? |
| Q36216393 | Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities |
| Q43590662 | Calmodulin activates intersubunit electron transfer in the neuronal nitric-oxide synthase dimer |
| Q46890656 | Carvedilol modifies antioxidant status of patients with stable angina |
| Q38044330 | Cell-specific insulin resistance: implications for atherosclerosis |
| Q35044339 | Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability |
| Q37173867 | Cellular signaling and NO production |
| Q39137289 | Central Role of Metabolism in Endothelial Cell Function and Vascular Disease |
| Q47996846 | Characterization of the murine endothelial nitric oxide synthase promoter |
| Q33777699 | Cholesterol lowering and endothelial function |
| Q33633032 | Chromatin-modifying agents convert fibroblasts to OCT4+ and VEGFR-2+ capillary tube-forming cells |
| Q36776710 | Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications. |
| Q44886433 | Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient mice |
| Q40807475 | Cinnamophilin as a novel antiperoxidative cytoprotectant and free radical scavenger. |
| Q31884454 | Clinical significance of determination of surrogate markers of angiogenesis in breast cancer |
| Q43857835 | Coordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cells |
| Q33959651 | Coronary microcirculation: physiology and pharmacology |
| Q37859787 | Current role of myeloperoxidase in routine clinical practice |
| Q33929217 | DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells |
| Q43826659 | Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy |
| Q42476408 | Decreased production of nitric oxide by peripheral blood mononuclear cells of patients with peripheral vascular disease |
| Q24812364 | Detection of reactive oxygen species in isolated, perfused lungs by electron spin resonance spectroscopy |
| Q73763953 | Detection of superoxide anion using an isotopically labeled nitrone spin trap: potential biological applications |
| Q42359645 | Dietary Plant Sterols Supplementation Increases In Vivo Nitrite and Nitrate Production in Healthy Adults: A Randomized, Controlled Study |
| Q43912971 | Dietary antioxidants preserve endothelium dependent vasorelaxation in overfed rats |
| Q43157324 | Dietary inhibition of xanthine oxidase attenuates radiation-induced endothelial dysfunction in rat aorta |
| Q44123462 | Dietary supplementation with vitamins C and E prevents downregulation of endothelial NOS expression in hypercholesterolemia in vivo and in vitro. |
| Q35202910 | Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO. |
| Q73545483 | Direct scavenging of nitric oxide by traditional crude drugs |
| Q44504070 | Distinct influence of N-terminal elements on neuronal nitric-oxide synthase structure and catalysis |
| Q47828364 | Domain swapping in inducible nitric-oxide synthase. Electron transfer occurs between flavin and heme groups located on adjacent subunits in the dimer. |
| Q47819353 | Effect of 20-HETE inhibition on L-NAME-induced hypertension in rats. |
| Q52911879 | Effect of Selenium Deficiency on Nitric Oxide and Heat Shock Proteins in Chicken Erythrocytes. |
| Q43601429 | Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects |
| Q54450946 | Effect of pentoxifylline on lung inflammation and gas exchange in a sepsis-induced acute lung injury model. |
| Q33814368 | Effect of redox-active drugs on superoxide generation from nitric oxide synthases: biological and toxicological implications |
| Q42585213 | Effect of reuse of polysulfone membrane on oxidative stress during hemodialysis |
| Q46729087 | Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells |
| Q44987508 | Effects of L-arginine supplementation on blood flow, oxidative stress status and exercise responses in young adults with uncomplicated type I diabetes |
| Q46363765 | Effects of antioxidants on endothelial function in human saphenous vein in an ex vivo model |
| Q37255741 | Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease |
| Q35624387 | Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells |
| Q34159834 | Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives |
| Q34379552 | Effects of exercise training on vascular function and myocardial perfusion |
| Q28191686 | Effects of low-dose aspirin on endothelial function in hypertensive patients |
| Q64999252 | Effects of neuromuscular electrical stimulation in patients with heart failure - review. |
| Q36242351 | Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol |
| Q43097995 | Effects of tadalafil on platelets and endothelium in patients with erectile dysfunction and cardiovascular risk factors: a pilot study |
| Q52674867 | Endothelial Dysfunction in Type 2 Diabetes Mellitus. |
| Q35161493 | Endothelial arginase II and atherosclerosis |
| Q38468879 | Endothelial argininosuccinate synthase mRNA 5'-untranslated region diversity. Infrastructure for tissue-specific expression |
| Q36093993 | Endothelial cell dysfunction: can't live with it, how to live without it. |
| Q35585925 | Endothelial control of vasomotion and nitric oxide production |
| Q46093210 | Endothelial dysfunction after hypoxia-reoxygenation: do in vitro models work? |
| Q38247988 | Endothelial dysfunction as a nexus for endothelial cell-cardiomyocyte miscommunication. |
| Q34456704 | Endothelial dysfunction associated with oxidative stress in human |
| Q47681488 | Endothelial dysfunction in patients with asthma: the role of polymorphisms of ACE and endothelial NOS genes |
| Q35813629 | Endothelial dysfunction, inflammation and diabetes |
| Q37773162 | Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus |
| Q30351081 | Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation. |
| Q85310796 | Endothelial nitric oxide synthase gene polymorphisms and the risk of acute myocardial infarction in a South Indian population |
| Q30861585 | Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment |
| Q37417272 | Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE. |
| Q35093076 | Endothelium and the lipid metabolism: the current understanding. |
| Q74086092 | Endothelium-dependent hyperpolarization as a remote anti-atherogenic mechanism |
| Q41813606 | Endothelium-derived hyperpolarizing factor and diabetes |
| Q30540016 | Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. |
| Q36404553 | Enhanced peroxynitrite formation is associated with vascular aging |
| Q44363823 | Enhanced vascular production of superoxide in OLETF rat after the onset of hyperglycemia |
| Q46747290 | Environmentally Realistic Doses of Cadmium as a Possible Etiologic Agent for Idiopathic Pathologies |
| Q36064170 | Epistatic interactions in idiopathic pulmonary arterial hypertension |
| Q44541761 | Ethnicity-specific differences in L-arginine status in South African men. |
| Q39737864 | Evidence for in vivo transport of bioactive nitric oxide in human plasma. |
| Q42721201 | Evidence suggesting a nitric oxide-scavenging activity for traditional crude drugs, and action mechanisms of Sanguisorbae Radix against oxidative stress and aging |
| Q41964128 | Exercise limitations in a competitive cyclist twelve months post heart transplantation |
| Q44559057 | Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations |
| Q30640089 | Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice |
| Q33557508 | Exploring epistatic relationships of NO biosynthesis pathway genes in susceptibility to CHD. |
| Q64109351 | Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects |
| Q55476366 | Expression of citrulline-nitric oxide cycle in lipopolysaccharide and cytokine-stimulated rat astroglioma C6 cells. |
| Q35026725 | Expression of eNOS in kidneys from hypertensive patients |
| Q22008706 | Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions |
| Q30704987 | Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice |
| Q55000595 | Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase. |
| Q35749187 | Fibronectin-alpha 4 beta 1 integrin-mediated blockade protects genetically fat Zucker rat livers from ischemia/reperfusion injury |
| Q35745853 | Free radicals and redox signalling in cardiovascular disease |
| Q34722600 | Free radicals, diabetes and endothelial dysfunction. |
| Q35792234 | Functional Expression of Endothelial Nitric Oxide Synthase Fused to Green Fluorescent Protein in Transgenic Mice |
| Q44315159 | Functional characterization of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system |
| Q35173610 | Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities |
| Q53443402 | H2O2 generated by NADPH oxidase 4 contributes to transient receptor potential vanilloid 1 channel-mediated mechanosensation in the rat kidney. |
| Q42576287 | HPLC analysis of tetrahydrobiopterin and its pteridine derivatives using sequential electrochemical and fluorimetric detection: application to tetrahydrobiopterin autoxidation and chemical oxidation |
| Q46247156 | Hemostasis, endothelial stress, inflammation, and the metabolic syndrome |
| Q46068004 | Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice |
| Q43912991 | Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells |
| Q33844099 | Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase |
| Q34956672 | Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide |
| Q35672600 | Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus |
| Q80579552 | Impairment of endothelium-dependent relaxation of aortas and pulmonary arteries from spontaneously hyperlipidemic mice (Apodemus sylvaticus) |
| Q77766237 | Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus |
| Q46869135 | In vivo reactive oxygen species production induced by ischemia in muscle arterioles of mice: involvement of xanthine oxidase and mitochondria |
| Q37356167 | Increased NO bioavailability in aging male rats by genistein and exercise training: using 4, 5-diaminofluorescein diacetate. |
| Q31722034 | Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure |
| Q53196491 | Increased oxidative stress from early pregnancy in women who develop preeclampsia. |
| Q36977226 | Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension |
| Q28350110 | Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice |
| Q35864675 | Inflammation as a Link between Obesity and Metabolic Syndrome |
| Q42517362 | Influence of intermittent hypoxia interval training on exercise-dependent erythrocyte NOS activation and blood pressure in diabetic patients |
| Q36969764 | Insulin resistance and endothelial cell dysfunction: studies in mammalian models |
| Q51499504 | Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxid |
| Q28609904 | Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis |
| Q44477930 | Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease |
| Q48025355 | Interactive effects of the ACE DD polymorphism with the NOS III homozygous G849T (Glu298-->Asp) variant in determining endothelial function in coronary artery disease |
| Q24814462 | Intercellular communication, NO and the biology of Chinese medicine |
| Q77994097 | Interleukin-1beta-induced nitric oxide production in rat aortic endothelial cells: inhibition by estradiol in normal and high glucose cultures |
| Q43917503 | Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells |
| Q89218939 | Involvement of CD8+ T cell subsets in early response to vascular injury in patients with peripheral artery disease in vivo |
| Q35047383 | Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1. |
| Q35339312 | Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction? |
| Q37038898 | Ischemia-reperfusion injury in rats affects hydraulic conductivity in two phases that are temporally and mechanistically separate |
| Q33621916 | Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage |
| Q35928417 | Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway |
| Q48006912 | Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation |
| Q35055189 | L-arginine in cardiovascular disease: dream or reality? |
| Q36995143 | Leptin-induced endothelial dysfunction in obesity. |
| Q40958378 | Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages |
| Q38766057 | Lipid levels and risk of venous thrombosis: results from the MEGA-study |
| Q46717243 | Lipopolysaccharide-induced alterations in oxygen consumption and radical generation in endothelial cells |
| Q54029918 | Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. |
| Q39867198 | Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species |
| Q33631306 | Mammalian nitric oxide synthases |
| Q44037751 | Measuring reactive oxygen species inhibition of endothelin-converting enzyme |
| Q28236507 | Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain |
| Q26851899 | Mechanosensitive microRNAs-role in endothelial responses to shear stress and redox state |
| Q37241510 | Membrane-initiated actions of estrogen on the endothelium |
| Q28395650 | Metal rich particulate matter impairs acetylcholine-mediated vasorelaxation of microvessels in mice |
| Q35026501 | Microcirculation as a target for the anti-inflammatory properties of statins. |
| Q34282667 | Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors |
| Q35136214 | Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions |
| Q36074410 | Modifying effect of intravenous laser therapy on the protein expression of arginase and epidermal growth factor receptor in type 2 diabetic patients |
| Q43094403 | Modulation of platelet aggregation, haematological and histological parameters by structured lipids on hypercholesterolaemic rats |
| Q36982120 | Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats. |
| Q24653742 | Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation |
| Q39947076 | More sweetness than light? A search for the causes of diabetic vasculopathy |
| Q35949620 | Myocardial angiogenesis |
| Q48827885 | NAD(P)H oxidase inhibiting with apocynin improved vascular reactivity in tail-suspended hindlimb unweighting rat. |
| Q33593365 | NAD(P)H oxidases in coronary artery disease. |
| Q45219974 | NOS3 is involved in the increased protein and arginine metabolic response in muscle during early endotoxemia in mice |
| Q36042624 | Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat. |
| Q87423997 | Neferine inhibits the upregulation of CCL5 and CCR5 in vascular endothelial cells during chronic high glucose treatment |
| Q43669929 | Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor. |
| Q35128290 | Neuroprotection mediated by changes in the endothelial actin cytoskeleton. |
| Q49050596 | Neutrophil superoxide anion--generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. |
| Q42948599 | Nitric oxide and myocardial function in heart failure: friend or foe? |
| Q44138643 | Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries |
| Q33537695 | Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links |
| Q37374087 | Nitric oxide synthases: which, where, how, and why? |
| Q28193414 | Nitric oxide-releasing aspirin decreases vascular injury by reducing inflammation and promoting apoptosis |
| Q35848552 | Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterin |
| Q36791018 | Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice |
| Q61842774 | Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans |
| Q73153916 | Oxidative injury of isolated cardiomyocytes: dependence on free radical species |
| Q42488126 | Oxidative stress and nitrite dynamics under maximal load in elite athletes: relation to sport type |
| Q36410733 | P-selectin glycoprotein ligand-1: a cellular link between perivascular adipose inflammation and endothelial dysfunction |
| Q34630994 | Paradoxical impairment of angiogenesis, endothelial function and circulating number of endothelial progenitor cells in DPP4-deficient rat after critical limb ischemia |
| Q33843544 | Pathophysiology of ischaemia-reperfusion injury |
| Q39607845 | Pathophysiology of portal hypertension and esophageal varices |
| Q34515458 | Pharmacological approaches to preserving and restoring coronary endothelial function |
| Q43930839 | Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease |
| Q36072052 | Pleiotropic effects of calcium channel blockers |
| Q24647863 | Pleiotropic effects of statins |
| Q50186670 | Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes. |
| Q37464262 | Postprandial hyperglycemia as an etiological factor in vascular failure |
| Q36993998 | Proton Pump Inhibitors Accelerate Endothelial Senescence |
| Q34980989 | QHREDGS enhances tube formation, metabolism and survival of endothelial cells in collagen-chitosan hydrogels. |
| Q37143595 | R-spondin3 prevents mesenteric ischemia/reperfusion-induced tissue damage by tightening endothelium and preventing vascular leakage |
| Q44613104 | Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function |
| Q34605419 | Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae |
| Q28076240 | Reactive Oxygen Species: A Key Hallmark of Cardiovascular Disease |
| Q35035263 | Reactive oxygen species as important determinants of medullary flow, sodium excretion, and hypertension |
| Q35874976 | Reactive oxygen species in vascular biology: implications in hypertension |
| Q35696507 | Reactive oxygen species in vascular biology: role in arterial hypertension |
| Q37270079 | Redox modulation of endothelial nitric oxide synthase by glutaredoxin-1 through reversible oxidative post-translational modification |
| Q35666358 | Redox processes underlying the vascular repair reaction |
| Q39506880 | Reduced spinal microglial activation and neuropathic pain after nerve injury in mice lacking all three nitric oxide synthases. |
| Q44167880 | Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide |
| Q28145799 | Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training |
| Q36342101 | Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice |
| Q46543297 | Relation of the Glu298Asp polymorphism of the nitric oxide synthase gene to hypertension and serum cholesterol in Japanese workers |
| Q43572177 | Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis |
| Q27021318 | Renal endothelial dysfunction in diabetic nephropathy |
| Q58566927 | Responses of Endothelial Cells Towards Ischemic Conditioning Following Acute Myocardial Infarction |
| Q37445518 | Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease |
| Q44177660 | Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets |
| Q22241432 | Role of HMG-CoA Reductase Inhibitors in Neurological Disorders |
| Q58551068 | Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis |
| Q35909718 | Role of L-arginine in the pathogenesis and treatment of renal disease |
| Q34028420 | Role of adhesion molecules in vascular regulation and damage |
| Q44182978 | Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries |
| Q41731426 | Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice |
| Q41349763 | Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis |
| Q33811437 | Role of inducible nitric oxide synthase in transplant arteriosclerosis |
| Q35920339 | Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms |
| Q43774403 | Role of iron in the interaction of red blood cells with methylglyoxal. Modification of L-arginine by methylglyoxal is catalyzed by iron redox cycling. |
| Q35090358 | Role of nitric oxide in the pathophysiology of heart failure |
| Q37429079 | Roles of IL-6-gp130 Signaling in Vascular Inflammation |
| Q37306295 | Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function |
| Q34254651 | Roles of tetrahydrobiopterin in promoting tumor angiogenesis |
| Q37226354 | Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium |
| Q38778791 | Selenium in the prevention of atherosclerosis and its underlying mechanisms. |
| Q34699955 | Shear stress-triggered nitric oxide release from Schlemm's canal cells |
| Q36817570 | Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. |
| Q33935039 | Slow and sustained nitric oxide releasing compounds inhibit multipotent vascular stem cell proliferation and differentiation without causing cell death |
| Q36941078 | Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells |
| Q34666839 | Statins and ischemic stroke |
| Q36984711 | Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor |
| Q28145487 | Superoxide regulation of endothelin-converting enzyme |
| Q46844836 | Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction. |
| Q85226108 | Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress |
| Q35036184 | Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis |
| Q73356301 | Tetrahydrobiopterin restores endothelial function in long-term smokers |
| Q24679740 | Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression |
| Q57066613 | The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation |
| Q64107836 | The Role of Traditional Chinese Medicine in the Regulation of Oxidative Stress in Treating Coronary Heart Disease |
| Q78115598 | The effect of cyst(e)ine on the auto-oxidation of homocysteine |
| Q42448372 | The effect of hypercholesterolemia on platelet soluble guanylyl cyclase |
| Q98292303 | The effects of microgravity and space radiation on cardiovascular health: From low-Earth orbit and beyond |
| Q37651334 | The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis |
| Q33243521 | The free-radical scavenger, edaravone, augments NO release from vascular cells and platelets after laser-induced, acute endothelial injury in vivo. |
| Q46068133 | The inhibition in tumor necrosis factor-alpha-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-kappaB and reactive oxygen species |
| Q28363031 | The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis |
| Q35055194 | The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function |
| Q36536154 | The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation |
| Q36761147 | The role of redox signaling in epigenetics and cardiovascular disease |
| Q26862336 | The role of sphingosine-1-phosphate in endothelial barrier function |
| Q35888589 | The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis |
| Q36996294 | Thiazolidinediones as anti-inflammatory and anti-atherogenic agents |
| Q43792229 | Thiol oxidase activity of copper, zinc superoxide dismutase |
| Q45217075 | Thrombin-induced rapid geranylgeranylation of RhoA as an essential process for RhoA activation in endothelial cells |
| Q45007909 | Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man. |
| Q48258483 | Transcriptional activation following cerebral ischemia in mice of a promoter-deleted nitric oxide synthase-2 gene |
| Q45888795 | Transfer and expression of recombinant nitric oxide synthase genes in the cardiovascular system |
| Q28259468 | Vascular actions of 20-HETE |
| Q80833901 | Vascular cell signaling by membrane estrogen receptors |
| Q34595721 | Vascular effects of dietary L-arginine supplementation |
| Q41862776 | Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. |
| Q33957964 | Vascular oxidant stress: molecular mechanisms and pathophysiological implications |
| Q33900440 | Visualizing inducible nitric-oxide synthase in living cells with a heme-binding fluorescent inhibitor |
| Q37230136 | Vitamin D receptor signaling in renal and cardiovascular protection |
| Q36065512 | Vitamin D receptor signaling inhibits atherosclerosis in mice |
| Q37494864 | Vitamin E and antioxidant activity; its role in slow coronary flow |
| Q54138041 | [Therapeutic options for improvement of myocardial perfusion in coronary atherosclerosis]. |
| Q37047148 | eNOS Glu298Asp Polymorphism and Endothelial Dysfunction in Patients with and without End-stage Renal Disease |
| Q35801497 | eNOS, a pressure-dependent regulator of intraocular pressure. |
| Q40781440 | hsp70-DnaJ chaperone pairs prevent nitric oxide-mediated apoptosis in RAW 264.7 macrophages |
| Q34504964 | microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis |
Search more.